Xilio Therapeutics
XLO
#9732
Rank
S$46.27 M
Marketcap
$0.89
Share price
-1.90%
Change (1 day)
-54.92%
Change (1 year)

EPS for Xilio Therapeutics (XLO)

EPS in 2023 (TTM): -$4.18

According to Xilio Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.16. In 2022 the company made an earnings per share (EPS) of -$4.36 a decrease over its 2021 EPS that were of -$4.18.

EPS history for Xilio Therapeutics from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.18-4.1%
2022-$4.364.42%
2021-$4.18